MAPT and Alzheimer disease: A study that has emerged for the first time describes an endogenous Tau protein in human DPSCs detected by its phosphorylated and unphosphorylated epitopes, demonstrating its potential to model normal Tau status and the possibility of inducing changes that mimic the modifications associated with neurodegeneration in AD [137].